Polycystic kidney, unspecified
ICD-10 Q61.3 is a billable code used to indicate a diagnosis of polycystic kidney, unspecified.
Polycystic kidney disease (PKD) is a genetic disorder characterized by the development of numerous cysts in the kidneys, leading to renal dysfunction. In pediatric patients, this condition can manifest as either autosomal dominant or autosomal recessive forms, with the latter often presenting in infancy or early childhood. The cysts can vary in size and number, causing the kidneys to enlarge and potentially leading to hypertension, hematuria, and renal failure. Diagnosis typically involves imaging studies such as ultrasound or MRI, which reveal the presence of cysts. Management may include monitoring renal function, controlling blood pressure, and addressing complications as they arise. In cases where renal failure occurs, renal replacement therapy or transplantation may be necessary. The unspecified designation indicates that the specific type of polycystic kidney disease has not been determined, necessitating further evaluation and genetic testing to ascertain the underlying cause.
Pediatric documentation should include growth parameters, renal function tests, and any associated symptoms such as hypertension or urinary issues.
Common scenarios include routine monitoring of renal function in children diagnosed with PKD, management of hypertension, and evaluation for renal transplantation.
Pediatric coders must be aware of the developmental implications of PKD and the need for multidisciplinary care involving nephrology and genetics.
Genetic documentation should include results of genetic testing, family pedigree, and any counseling provided to the family regarding inheritance patterns.
Genetic counseling sessions for families with a history of PKD, assessment of risk for future pregnancies, and interpretation of genetic test results.
Genetic coders must ensure accurate coding of both the condition and any related genetic syndromes, as well as the implications for family members.
Used to evaluate renal cysts in suspected cases of PKD.
Documentation must include indications for the ultrasound and findings related to renal structure.
Pediatric specialists should ensure that the ultrasound is interpreted in the context of the patient's age and clinical history.
Ordered to confirm diagnosis of PKD and assess genetic risk.
Documentation should include family history and rationale for genetic testing.
Geneticists must provide detailed reports on the implications of test results for the patient and family.
Autosomal dominant PKD typically presents in adulthood with fewer cysts, while autosomal recessive PKD often presents in infancy with more severe symptoms and a higher risk of renal failure. Genetic testing can help determine the specific type.
